SLDB
Solid Biosciences Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +11.1% ·
share flow +3.1% ·
net new positions +10.0%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 72 | +6 | 45.63M | $455.47M | +9 | −3 |
| Q1 2026 | 69 | 0 | 38.87M | $279.42M | +3 | −3 |
| Q4 2025 | 68 | +2 | 30.07M | $169.59M | +2 | — |
| Q3 2025 | 17 | +1 | 23.96M | $147.82M | +1 | — |
| Q2 2025 | 13 | -1 | 26.02M | $126.70M | +1 | −2 |
| Q1 2025 | 11 | +1 | 11.02M | $40.79M | +3 | −2 |
| Q4 2024 | 10 | -1 | 4.93M | $19.74M | +1 | −2 |
| Q3 2024 | 10 | +1 | 5.36M | $37.37M | +1 | — |
| Q2 2024 | 9 | — | 5.20M | $29.49M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 1.75M | -10.2% | $12.23M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Millennium Management ✦ | 1.12M | -35.4% | $7.79M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 920.46K | +718.8% | $6.42M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 504.87K | -1.7% | $3.52M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 504.87K | -1.7% | $3.52M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Point72 Asset Management ✦ | 443.01K | +292.8% | $3.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 202.96K | +9.1% | $1.41M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Marshall Wace ✦ | 187.37K | -31.6% | $1.31M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Marshall Wace ✦ | 187.37K | -31.6% | $1.31M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 119.80K | +183.6% | $835,034 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 119.80K | +183.6% | $835,034 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 73.21K | -73.6% | $510,288 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 37.94K | New | $264,414 | 0.0% | New | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 37.94K | New | $264,414 | 0.0% | New | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 37.94K | New | $264,414 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| AQR Capital Management | $264,414 | 0.0% |
| AQR Capital Management | $264,414 | 0.0% |
| AQR Capital Management | $264,414 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 137 holders, 96.05M shares, $689.27M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.